Synthetic Biology MRes

This MRes programme aims to train students in the fast-growing area of synthetic biology, a discipline which takes the knowledge and understanding we now have of the individual parts of biological systems and uses them in a defined way to design and build novel artificial biological systems. Students develop an understanding of the areas involved in synthetic biology, including engineering principles, mathematical modelling, advanced molecular biology, microbiology, biochemical engineering and necessary chemistry. Modules also provide the necessary skills for acquisition and critical analysis of the primary scientific literature and transferable research development skills. This programme includes a major research project that will provide in-depth training in synthetic biology research methods.

This Synthetic Biology MRes will qualify students to explore work within the growing number of small companies engaged in synthetic biology both here in London and across the UK and the world. There are many large companies that are building their own synthetic biology potential and some of our students are already working with these groups. Our students often go on to do further research in PhDs and EngDs globally. Our graduates have practical experience of generating novel research with our unique facilities that makes them of great value to employers and collaborators. Some of our MRes graduates have set up their own synthetic biology spin-out companies.

Synthetic biology is a fast growing area of research and will have a major economic and social impact on the global economy in the coming decades. The involvement of molecular biologists, biochemists, engineers, physical scientists, chemists and biologists can create designed cells, enzymes and biological modules that can be combined in a defined manner. These can be used to make complex metabolic pathways for pharmaceuticals, designed and synthetic cells, novel hybrid biosensors or novel routes to biofuels. A future integration of biological devices and hybrid devices as components in the electronics industry might lead to a whole new high value industry for structured biological entities.